| Followers | 68 |
| Posts | 2027 |
| Boards Moderated | 0 |
| Alias Born | 09/27/2011 |
Wednesday, December 25, 2013 10:22:36 AM
Make no mistake ..... Chemo is "big business" ..... costing patients 7-8 thousand per month .....
SKTO looked for viable treatment alternatives to challenge chemo protocol regarding such poor recovery rates ..... Which seems necessary and reasonable ..... Berkeley Bio-Organic Research Lab is located by SKTO and purchased to help move this issue forward ..... BBO comes with a distinguished history tethered to D. Gold ..... Oh yeah ..... the story gets even better and grows with optimism toward finding relief for cancer victims ..... while market sentiment seems to enjoy trivializing the scientific fact that Cannabis-Hemp are known to kill cancer cells ..... Good thing Dharma Care and Hospice Center has been in the picture for several years ..... a very potent ingredient of the picture ..... since the chain of results Dharma Care pioneered in respect to cannabis-hemp protocols with terminal patients ..... has now become years of history ..... and calls for evaluation .....
Note the distinguished credentials of D. Gold and Dr. Apel ..... Of course Mr. Gold might help facilitate bank accounts of chemo-lovers to quiver .....
MIAMI, FL--(Marketwired - Apr 29, 2013) - SK3 Group, Inc. (OTC Pink: SKTO) announces today that it has signed a definitive agreement to acquire Berkeley Bio-Organic Research Laboratories, a firm devoted to developing the pure science of cannabis medicine. Berkeley Bio-Organic Research Laboratory ("Berkeley Bio") was formed as a partnership in 2011 by Dr. Charles Apel, Ph.D. and David Hoye, who has been a well-known cannabis researcher and author since the early 1970's under the pseudonym "D. Gold."
While the firm itself is new, Mr. Hoye and Dr. Apel began working together about forty years ago when Dr. Apel helped Hoye develop the methods in Hoye's book, D. Gold; Cannabis Alchemy, Methods for Preparation of Extremely Potent Cannabis Products in 1972. The book, still in print and available on amazon.com among other outlets, has sold over 100,000 copies over the years and is recognized as the standard work on cannabis extraction and concentration. It was the first book published to present cannabis technology from a consumer's point of view.
Hoye went on, through numerous books, products and inventions, to become an authority and household name, again as D. Gold, in the world of scientific cannabis culture and technology. He opened the first new legal dispensary in San Francisco in 1996 after the passage of prop. 215, and founded the Dharma Patients Cooperative non-profit (now Dharma Care and Hospice Program) in 2006, which supplies free medicine to terminal hospice patients in California who have been recommended cannabis medicine by their doctor, but cannot afford it.. Recently Hoye penned the soon-to-be-published, Cannabis Chemotherapy, a compendium of scientific literature demonstrating the efficacy of concentrated cannabis medicine in treating cancer.
Dr. Apel has devoted much of his life to pure science, obtaining his PH. D in chemistry from University of California. Dr. Apel then conducted original research which showed that life on earth originated from freshwater ponds struck by lightning, instead of crawling from the sea. Dr. Apel has presented his findings at major universities around the world. Dr. Apel is a Postdoctoral Fellow in the astrochemistry branch of the Space Science Division of NASA/Ames Research Center, a research scientist with SETI (Search for Extraterrestrial Intelligence), has served as a consultant to the Artificial Life Project at Los Alamos National Laboratory, a Lecturer in Biochemistry at San Jose State University, and is the Chief Science Officer at Berkeley Bio-Organic Research Laboratory. Dr. Apel is also an Associate Editor of Biosystems Journal.
The main concentration of Berkeley Bio is the development and production of non-psychoactive cannabinoid medicines, primarily for the treatment of cancer, allowing patients to obtain medically efficacious doses without attendant, and possibly negative, psychoactive consequences. A secondary interest is the development and production of equipment for the manufacture and production of cannabinoid-based medicines. Berkeley Bio has made substantial strides in these areas.
insert-text-here
And really ..... IMO ..... this is merely the tip-of-the-iceberg for those thinking ahead ..... while the reaper stands by with a handy scythe ..... slicing a portion of fat from budding markets ..... lifted from the pockets of an ethical working class .....
Every single "Green-Sector" message board I visit has critics tearing the personnel and companies apart ..... while special interests fight to keep truth hidden ..... and grease effective channels ..... Sure ..... I see the prize for some is money ..... but Dr. Gold has a history of caring ..... People are feeling weary from the ongoing shakedown ..... and looking toward recovery and optimism ..... The Backward-Looking-People are fighting to control the Forward-Looking-People ..... by force ..... in a declared democracy ..... How ironic!!!!! ..... which is why the "tight-ones" are obviously endocannabinoid deficient in the first place ..... and too proud to learn ..... though a few might get lucky and sample tasty edibles ..... when they learn about the effects of reduced pain and relaxation from cannabis medicine .....
I've been bothered for months after learning the real fluoride story told by ..... "The Great Culling" ..... Exactly why does most of America's domestic water treatment policy dump toxic chemicals purchased from China into our tap-water????? ..... under a phony pretext of reducing cavities????? ..... This is precisely the same type of closed-minded obstructive thinking one observes manipulating sentiment in all the Cannabis-Hemp markets ..... The one-person ..... one-vote at a time appears to be the only tool in the picture with the power to transform evil ..... Best Wishes .....
And Merry Christmas to all .....
